The Karma system is currently undergoing maintenance (Monday, January 29, 2018).
The maintenance period has been extended to 8PM EST.

Karma Credits will not be available for redeeming during maintenance.

JMIR Dermatology

Advertisement

Journal Description

JMIR Dermatology (JDerm) is a new sister journal of JMIR (the leading open-access journal in health informatics (Impact Factor 2016: 5.175), focusing on technologies, medical devices, apps, engineering, informatics applications for patient education in dermatology, including preventative interventions (e.g. skin cancer prevention) and clinical care for dermatological populations.

As open access journal we are read by clinicians and patients alike and have (as all JMIR journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies. We publish original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews).

During a limited period of time, there are no fees to publish in this journal. Articles are carfully copyedited and XML-tagged, ready for submission in PubMed Central.

Be a founding author of this new journal and submit your paper today!

 

Recent Articles:

  • Source: Image created by the Authors; Copyright: The Authors; URL: http://derma.jmir.org/2018/1/e1/; License: Creative Commons Attribution (CC-BY).

    Social Media as a Platform for Information and Support for Melanoma Patients: Analysis of Melanoma Facebook Groups and Pages

    Abstract:

    Background: Social media is increasingly used as a source of health information and is useful for information exchange and patient support. Objective: The aim of this study is to describe the Facebook groups and pages that are available for melanoma patients. Methods: A systematic search of Facebook groups and pages was performed using the word “melanoma.” The first 50 pages found in the search, sorted by most relevant, were analyzed for several characteristics, namely page name, category, verification status, number of likes, number of followers, visitor posts per week, page posts per week, ability to donate, date of inception, and for-profit or nonprofit. The first 50 groups found in the search, sorted by most relevant, were analyzed for name, category, number of members, and privacy setting. Results: There were 669 pages and 568 groups related to melanoma found on Facebook. The first 50 pages had a combined total of 266,709 likes and 257,183 followers and, of these, 30% (15/50) were verified by Facebook. Within the analyzed Facebook pages, the average number of visitor posts per week was 0.48, the average number of posts by the page per week was 5.6, and the most common page categories were community and nonprofit. Of the 50 groups analyzed, 18 were public and 32 were private (closed). The total number of combined group members in all 50 groups was found to be 23,047 and 52% (26/50) of the groups were categorized as support. Conclusions: Melanoma pages and groups on Facebook reach a large portion of the population. To provide resources for the population of patients diagnosed with malignant melanoma and ensure that proper information is distributed, physicians and health care organizations may consider using Facebook as a platform to support and educate patients with melanoma.

  • Source: Image created by the authors; Copyright: The Authors; URL: http://derma.jmir.org/2018/1/e1/; License: Creative Commons Attribution (CC-BY).

    Acceptability and Feasibility of a Trial Testing Allocation to Sunscreen and a Smartphone App for Sun Protection: Discontinued Randomized Controlled Trial

    Abstract:

    Background: Recreational sun exposure has been associated with melanoma prevalence, and tourism settings are of particular interest for skin cancer prevention. Effective, affordable, and geographically flexible interventions to promote sun protection are needed. Objective: The aim of this study was to describe the protocol for a definitive randomized controlled trial (RCT) evaluating a smartphone mobile intervention (mISkin app) promoting sun protection in holidaymakers and to assess the acceptability and feasibility of the mISkin app and associated trial procedures in an internal pilot study. Methods: Participants were recruited from the general community. Holidaymakers traveling abroad and owning a smartphone were enrolled in the internal pilot of a 2 (mISkin vs control) x 2 (sun protection factor [SPF] 15 vs SPF 30) RCT with a postholiday follow-up. The smartphone app is fully automated and entails a behavioral intervention to promote sun protection. It consisted of five components: skin assessment, educational videos, ultraviolet (UV) photos, gamification, and prompts for sun protection. Participants were also randomly allocated to receive sunscreen SPF 15 or SPF 30. Primary outcomes for the internal pilot study were acceptability and feasibility of trial procedures and intervention features. Secondary outcomes were collected at baseline and after holidays through face-to-face-assessments and included skin sun damage, sunscreen use (residual weight and application events), and sun protection practices (Web-based questionnaire). Results: From 142 registers of interest, 42 participants were randomized (76% [32/42] female; mean age 35.5 years). Outcome assessments were completed by all participants. Random allocation to SPF 15 versus SPF 30 was found not to be feasible in a definitive trial protocol. Of the 21 people allocated to the mISkin intervention, 19 (91%) installed the mISkin on their phones, and 18 (86%) used it at least once. Participants were satisfied with the mISkin app and made suggestions for further improvements. Due to difficulties with the random allocation to SPF and slow uptake, the trial was discontinued. Conclusions: The internal pilot study concluded that randomization to SPF was not feasible and that recruitment rate was slower than expected because of difficulties with gatekeeper engagement. Possible solutions to the problems identified are discussed. Further refinements to the mISkin app are needed before a definitive trial. Trial Registration: International Standard Randomized Controlled Trial Number ISRCTN63943558; http://www.isrctn.com/ISRCTN63943558 (Archived by WebCite at http://www.webcitation.org/6xOLvbab8)

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Latest Submissions Open for Peer-Review:

View All Open Peer Review Articles
  • Applying social network analysis to the pattern of international author collaboration on the topic of skin cancer

    Date Submitted: May 9, 2018

    Open Peer Review Period: May 12, 2018 - Jul 7, 2018

    Background: Google Maps and social network analysis (SNA) are cutting edge methods and technologies that provide an insight into the big data and data analytics for readers to understand the pattern o...

    Background: Google Maps and social network analysis (SNA) are cutting edge methods and technologies that provide an insight into the big data and data analytics for readers to understand the pattern of phenomena we concern. Dominant nations in the long term are from the U.S. and Europe in science. Whether the trend has been changed, particularly on the topic of dermatology and cancer, requires studying and visual analytics using Google maps and SNA. Objective: To apply SNA to the pattern of international author collaborations on the topic of dermatology and cancer using data from Medline and to visualize the results on the Google Maps. Methods: We obtained 44,411 abstracts on April 12, 2018, from Medline based on the keywords of dermatology and cancer since 1950. The author names, countries/areas, and journals were recorded. We disclosed following features: (1) nation distribution for 1st author’s and most popular journals; (2) four stages’ pattern of international author collaborations on Google Maps with two types of displays(by continents and clusters), (3) network density used for evaluating the trend change of the international author collaborations and Kendall’s coefficient (W) used for determining the concordance to the trend; (4) the number of paper publications is association with the country’s gross domestic product (GDP). We programmed Microsoft Excel VBA routines to extract data from Medline. Google Maps and SNA Pajek software were performed to display the graphical representations. Results: We found that (1) the most number of papers on the topic of dermatology and cancer are from the U.S.(13,805, 34.34%), Germany(4,261,10.60%), and Japan( 4,042, 10.05%); (2)both patterns of international author collaborations (by continents and clusters) display on Google Maps with an easy-to-read feature for readers; (3) Kendall’s coefficient shows a significant concordance (W=0.91, =16.4, d.f.=3, p<0.001) in author collaboration trend across four classified stages over the years;(4) the correlation coefficient between the number of paper publications and the country’s GDP is 0.74(t=11.46). Conclusions: Social network analysis provides wide and deep insight into the relationships with the pattern of international author collaborations among nations. The results can provide readers with knowledge and concept maps for understanding the trend of paper publications on the topic of dermatology and cancer.

Advertisement